ReviewBreathing challenges in Rett Syndrome: Lessons learned from humans and animal models☆,☆☆
Introduction
Rett Syndrome (RTT) affects approximately 1 in 10,000 female births (Laurvick et al., 2006, Neul et al., 2010). Children with RTT develop apparently normal until the age of 18 months. At this age, most patients with RTT achieve the normal milestones with regards to motor functions and communication skills. But subsequently girls enter a stagnation phase (Hagberg, 2005) that is followed by a developmental regression (Neul, 2012). This regression is characterized by a loss of hand skills, mobility skills, and speech, and the girls typically show stereotypic hand movements, develop ataxia, gait apraxia and often seizures. Microcephaly, growth deficits, scoliosis are also characteristic features (Weng et al., 2011a). The loss of communication skills is one of the reasons why RTT is categorized as an autism spectrum disorder (Castro et al., 2013, Neul, 2012).
Among the core symptoms of RTT, severe disturbances in breathing are particularly devastating (Glaze, 2005, Katz et al., 2009, Kerr, 1992, Ogier and Katz, 2008, Rohdin et al., 2007, Weese-Mayer et al., 2008, Weese-Mayer et al., 2006). 65–93% of RTT patients display bouts of hypoventilation that alternate with irregular breathing or hyperventilation (Amir et al., 2000, Julu et al., 2001). But the breathing disturbances are variable and a large catalog of disturbances has been reported (Kerr, 1992). The breathing abnormalities have been categorized by various authors as periods of forced breathing, deep breathing, hyperventilation (rapid shallow breathing), hypoventilation, central and obstructive apneas, apneustic breathing, Valsalva's maneuvers, Biot's breathing, periodic breathing and breath holds (Julu et al., 2001, Weese-Mayer et al., 2008). Moreover, many of these breathing disturbances are associated with a significant dysregulation in cardio-respiratory coupling (Julu et al., 2001, Weese-Mayer et al., 2008). The complexity of the breathing phenotype in Rett Syndrome is in part explained by differences in the genotype/phenotype relationships, specifically the types of mutation and degree of X-chromosome inactivation (Amir et al., 2000).
Section snippets
The genetic basis of Rett Syndrome
Rett Syndrome is caused by a mutation in the methyl-CpG binding protein 2 (MECP2) gene (Amir et al., 1999). The genomic locus of MECP2 in humans is approximately 80 kb and consists of 4 exons from which two different isoforms of MeCP2 may be transcribed, differing in their inclusion of the second exon. The basic structure of the MECP2 locus and protein is conserved across species. Absence of the second intron allows for translation from the first exon and is referred to as the MeCP2e1 isoform,
Breath-holds and apneic events in Rett Syndrome
Breath holds or apneic events are consistently observed in RTT (Fig. 2, Fig. 3) (Weese-Mayer et al., 2008). These events have a periodic nature (Fig. 2A) and they are interspersed by bouts of hyperventilation and irregular breaths (Julu et al., 2001, Southall et al., 1988, Weese-Mayer et al., 2008).
Yet, defining these breathing cessations has been the source of considerable confusion. Indeed, the same type of events may have been described by different authors as “breath-hold”, “apnea” or
Hyperventilation and breath-to-breath irregularities
Hyperventilation associated with breath-to-breath irregularities is another characteristic disturbance in RTT patients (Southall et al., 1988, Weese-Mayer et al., 2008). The breaths in these patients are on average deeper, faster and more irregular in amplitude and timing (Weese-Mayer et al., 2008). However, the degree of these disturbances varies from individual to individual (Julu et al., 2001, Southall et al., 1988). Hyperventilation seems to be generated centrally as it is neither
Breathing disturbances in mouse models of RTT syndrome
The discovery that RTT is caused by a mutation in Mecp2 (Amir et al., 1999) facilitated animal studies aimed at mechanistically explaining the devastating symptoms of this disorder. Two mouse lines were developed in the laboratories of Rudolph Jaenisch and Adrian Bird in which Mecp2 was conditionally knocked-out: Mecp2™1Jae and Mecp2™1Bird (Chen et al., 2001, Guy et al., 2001). Initial characterization of breathing abnormalities was performed using null alleles of Mecp2 derived from the
Neuronal basis of breathing disturbances in RTT
Different aspects of breathing are controlled by different components of the respiratory network (Ramirez et al., 2011). By using conditional alleles of Mecp2 and monitoring the consequences in in vitro experiments it is possible to dissect which areas contribute to what aspects of RTT disturbances. Restoring MeCP2 to regions in the medulla and caudal pons restores a normal hypoxic breathing response (Ward et al., 2011). This is consistent with the role of the ventrolateral medulla, in
Disturbances in different interacting mechanisms may give rise to the RTT phenotype
The mouse models revealed a wide range of neuronal mechanisms that likely play a role also in human RTT patients (Fig. 5). Particularly important for the pathogenesis of breathing as well as other clinical phenotypes of RTT are (a) imbalances in synaptic transmission (Chao et al., 2010, Gatto and Broadie, 2010, Kron et al., 2012, Medrihan et al., 2008, Nelson et al., 2011, Shepherd and Katz, 2011, Zoghbi, 2003), and (b) alterations in a variety of neuromodulatory systems (Ladas et al., 2009,
Translational considerations
The complexity of the clinical phenotypes in RTT and the underlying mechanisms can be very discouraging to those trying to manage this devastating neurological disorder in human patients. Although, some improvement in the breathing disturbances have been reported in small trials and case reports (Andaku et al., 2005), large systematic clinical trials have not delivered reliable treatment avenues. Thus, there is a desperate need for novel therapies for the breathing disorder in RTT.
Several
Conclusions
Breathing abnormalities belong to the most detrimental clinical phenotype in RTT. These problems are associated with severe central dysautonomia that are worse during wakefulness. Other symptoms associated with RTT, such as increased anxiety further exacerbate the breathing disturbances. Although, disturbances in neuronal network functions can be observed early on, many symptoms become overt only later during postnatal development. Modern genetic and neurophysiological tools have led to a
References (85)
- et al.
Buspirone in Rett syndrome respiratory dysfunction
Brain & Development
(2005) - et al.
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression
Neuron
(2006) - et al.
Systemic oxidative stress in classic Rett syndrome
Free Radical Biology & Medicine
(2009) - et al.
Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth
Respiratory Physiology & Neurobiology
(2009) - et al.
Rett syndrome in Australia: a review of the epidemiology
Journal of Pediatrics
(2006) - et al.
Epac-mediated cAMP-signalling in the mouse model of Rett Syndrome
Neuropharmacology
(2011) - et al.
The nature of the nonventilatory period in crocodillan respiration
Respiration Physiology
(1971) - et al.
Breathing dysfunction in Rett syndrome: understanding epigenetic regulation of the respiratory network
Respiratory Physiology & Neurobiology
(2008) - et al.
Disturbances in cardiorespiratory function during day and night in Rett syndrome
Pediatric Neurology
(2007) - et al.
Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and Met
Current Opinion in Neurobiology
(2011)
Acute intermittent hypoxia-induced expression of brain-derived neurotrophic factor is disrupted in the brainstem of methyl-CpG-binding protein 2 null mice
Neuroscience
Physiological definition of upper airway obstructions in mouse model for Rett syndrome
Respiratory Physiology & Neurobiology
Early breathing defects after moderate hypoxia or hypercapnia in a mouse model of Rett syndrome
Respiratory Physiology & Neurobiology
Rett syndrome: from bed to bench
Pediatrics and Neonatology
Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal
Neuroscience
Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model
Respiratory Physiology & Neurobiology
Correction of respiratory disorders in a mouse model of Rett syndrome
Proceedings of the National Academy of Sciences of the United States of America
MeCP2: structure and function
Biochemistry and Cell Biology=Biochimie et Biologie Cellulaire
Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes
Annals of Neurology
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Nature Genetics
A critical and cell-autonomous role for MeCP2 in synaptic scaling up
Journal of Neuroscience
Cycle-by-cycle assembly of respiratory network activity is dynamic and stochastic
Journal of Neurophysiology
Patterns of inspiratory phase-dependent activity in the in vitro respiratory network
Journal of Neurophysiology
Mechanisms and therapeutic challenges in autism spectrum disorders: insights from Rett syndrome
Current Opinion in Neurology
MeCP2, a key contributor to neurological disease, activates and represses transcription
Science
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
Nature
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
Nature Genetics
Postnatal Inactivation Reveals Enhanced Requirement for Mecp2 at Distinct Age Windows
Neurogenesis of respiratory rhythm in the mammal
Physiological Reviews
FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice
Human Molecular Genetics
Wild-type microglia arrest pathology in a mouse model of Rett syndrome
Nature
Differential distribution of the MeCP2 splice variants in the postnatal mouse brain
Journal of Comparative Neurology
Heart rate response to the Valsalva maneuver as a test of circulatory integrity
JAMA
Hydrogen peroxide differentially affects activity in the pre-Botzinger complex and hippocampus
Journal of Neurophysiology
Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models
Frontiers in Synaptic Neuroscience
Neurophysiology of Rett syndrome
Journal of Child Neurology
Reversal of neurological defects in a mouse model of Rett syndrome
Science
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Nature Genetics
Rett syndrome: long-term clinical follow-up experiences over four decades
Journal of Child Neurology
Graded reductions in oxygenation evoke graded reconfiguration of the isolated respiratory network
Journal of Neurophysiology
7,8-Dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome
Journal of Applied Physiology
Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder
Archives of Disease in Childhood
Cited by (99)
Control of Breathing and Central Hypoventilation Syndromes
2023, Sleep Medicine ClinicsNeurologic Disorders in Women and Sleep
2023, Neurologic ClinicsRecovery of the biphasic hypoxic ventilatory response in neonatal rats after chronic hyperoxia
2023, Respiratory Physiology and NeurobiologyMECP2 Dysautonomia Phenotypes in Boys
2022, Pediatric NeurologyBreathing disturbances in Rett syndrome
2022, Handbook of Clinical NeurologyCitation Excerpt :It is thought that MECP2 likely contributes to an imbalance in excitatory and inhibitory processing in the NTS, known to be critical for the hypoxic response (Tabata et al., 2001). The NTS-mediated afferent input regulates both medullary and pontine activity (Wittman et al., 2019), and the consequences of a MECP2 mutation may be even more far-reaching, given that the NTS receives important peripheral sensory inputs, not only from the carotid body, but also from lung mechanoreceptors (Kubin et al., 1985; Paton, 1998; Ezure et al., 2002; Moreira et al., 2007; Kline et al., 2010; Ramirez et al., 2013a). Interestingly, restoring MECP2 in the brainstem regions defined by the HOXB1 gene rescued only the hypoxic response, but not basal hyperventilation.
- ☆
This paper is part of a special issue entitled “Clinical Challenges to Ventilatory Control”, guest-edited by Dr. Gordon Mitchell, Dr. Jan-Marino Ramirez, Dr. Tracy Baker-Herman and Dr. Dr. David Paydarfar.
- ☆☆
Support: This work was supported by NIH grants P01HL090554 (JMR), R01HL107084 (JMR), F31NS066601 (CSW), and R01HD062553 (JLN).